Curcumin: recent updates on gastrointestinal cancers

[1]  D. Lim.  3-O-Ethyl-L-Ascorbic Acid Doped Enteric-Coated Gelatin Capsules towards the Advanced Oral Curcumin Delivery for Cancers , 2022, Polymers.

[2]  F. Gao,et al.  Pancreatic cancer: A review of epidemiology, trend, and risk factors , 2021, World journal of gastroenterology.

[3]  K. El-Tarabily,et al.  Curcumin, the active substance of turmeric: its effects on health and ways to improve its bioavailability. , 2021, Journal of the science of food and agriculture.

[4]  A. Jemal,et al.  Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries , 2021, CA: a cancer journal for clinicians.

[5]  P. Somvanshi,et al.  Reductive metabolites of curcumin and their therapeutic effects , 2020, Heliyon.

[6]  M. Ashrafizadeh,et al.  Sensing the scent of death: Modulation of microRNAs by curcumin in gastrointestinal cancers. , 2020, Pharmacological research.

[7]  R. Pandey,et al.  Clinical profile of lung cancer in North India: A 10-year analysis of 1862 patients from a tertiary care center , 2020, Lung India : official organ of Indian Chest Society.

[8]  Edward L. Giovannucci,et al.  Global Burden of 5 Major Types Of Gastrointestinal Cancer. , 2020, Gastroenterology.

[9]  Hongliang Liu,et al.  CSN5 upregulates glycolysis to promote hepatocellular carcinoma metastasis via stabilizing the HK2 protein. , 2020, Experimental cell research.

[10]  A. Mahmoud,et al.  Curcumin and Selenium Prevent Lipopolysaccharide/Diclofenac-Induced Liver Injury by Suppressing Inflammation and Oxidative Stress , 2019, Biological Trace Element Research.

[11]  Yi-yu Qin,et al.  Overexpression of SNORA21 suppresses tumorgenesis of gallbladder cancer in vitro and in vivo. , 2019, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[12]  Gautam Sethi,et al.  Honokiol for cancer therapeutics: A traditional medicine that can modulate multiple oncogenic targets. , 2019, Pharmacological research.

[13]  R. Bronson,et al.  The Combination of Curcumin and Salsalate is Superior to Either Agent Alone in Suppressing Pro‐Cancerous Molecular Pathways and Colorectal Tumorigenesis in Obese Mice , 2019, Molecular nutrition & food research.

[14]  A. Avan,et al.  Phytosomal Curcumin Elicits Anti-tumor Properties Through Suppression of Angiogenesis, Cell Proliferation and Induction of Oxidative Stress in Colorectal Cancer. , 2019, Current pharmaceutical design.

[15]  Wei Zhang,et al.  Curcumin inhibits liver metastasis of gastric cancer through reducing circulating tumor cells , 2019, Aging.

[16]  T. Brzozowski,et al.  Curcumin: A Potent Protectant against Esophageal and Gastric Disorders , 2019, International journal of molecular sciences.

[17]  W. Sha,et al.  Curcumin regulates the miR-21/PTEN/Akt pathway and acts in synergy with PD98059 to induce apoptosis of human gastric cancer MGC-803 cells , 2019, The Journal of international medical research.

[18]  Gang Yin,et al.  Combination of Astragali Polysaccharide and Curcumin Improves the Morphological Structure of Tumor Vessels and Induces Tumor Vascular Normalization to Inhibit the Growth of Hepatocellular Carcinoma , 2019, Integrative cancer therapies.

[19]  Y. Liu,et al.  The natural polyphenol curcumin induces apoptosis by suppressing STAT3 signaling in esophageal squamous cell carcinoma , 2018, Journal of Experimental & Clinical Cancer Research.

[20]  S. Porav,et al.  Co-delivery of curcumin and doxorubicin in PEGylated liposomes favored the antineoplastic C26 murine colon carcinoma microenvironment , 2018, Drug Delivery and Translational Research.

[21]  T. Slaga,et al.  Inhibition of skin tumor promotion by TPA using a combination of topically applied ursolic acid and curcumin , 2018, Molecular carcinogenesis.

[22]  Piul S. Rabbani,et al.  Dysregulation of Nrf2/Keap1 Redox Pathway in Diabetes Affects Multipotency of Stromal Cells , 2018, Diabetes.

[23]  S. M. Taghdisi,et al.  Curcumin‐entrapped MUC‐1 aptamer targeted dendrimer‐gold hybrid nanostructure as a theranostic system for colon adenocarcinoma , 2018, International journal of pharmaceutics.

[24]  J. Frank,et al.  Micellar solubilisation enhances the antiinflammatory activities of curcumin and boswellic acids in rats with adjuvant-induced arthritis. , 2018, Nutrition.

[25]  S. Toden,et al.  A combination of curcumin and oligomeric proanthocyanidins offer superior anti-tumorigenic properties in colorectal cancer , 2018, Scientific Reports.

[26]  P. Wei,et al.  Heat shock protein 27 influences the anti‐cancer effect of curcumin in colon cancer cells through ROS production and autophagy activation , 2018, Life sciences.

[27]  Do-Hee Kim,et al.  Curcumin suppresses oncogenicity of human colon cancer cells by covalently modifying the cysteine 67 residue of SIRT1. , 2018, Cancer letters.

[28]  Z. Meng,et al.  Cancer-Associated Fibroblasts in Pancreatic Cancer: Should They Be Deleted or Reeducated? , 2018, Integrative cancer therapies.

[29]  Geeta Arya,et al.  Evaluation of curcumin loaded chitosan/PEG blended PLGA nanoparticles for effective treatment of pancreatic cancer. , 2018, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[30]  H. Suleria,et al.  Cucurmin, anticancer, & antitumor perspectives: A comprehensive review , 2018, Critical reviews in food science and nutrition.

[31]  Yue Guo,et al.  DNA methylome and transcriptome alterations and cancer prevention by curcumin in colitis-accelerated colon cancer in mice , 2018, Carcinogenesis.

[32]  A. Chauhan,et al.  Synthesis of novel Chlorin e6-curcumin conjugates as photosensitizers for photodynamic therapy against pancreatic carcinoma. , 2018, European journal of medicinal chemistry.

[33]  C. Polaquini,et al.  Curcumin Analog CH-5 Suppresses the Proliferation, Migration, and Invasion of the Human Gastric Cancer Cell Line HGC-27 , 2018, Molecules.

[34]  S. Law,et al.  Preclinical Study of Novel Curcumin Analogue SSC-5 Using Orthotopic Tumor Xenograft Model for Esophageal Squamous Cell Carcinoma , 2018, Cancer research and treatment : official journal of Korean Cancer Association.

[35]  Hanmin Li,et al.  Antitumor activities of novel glycyrrhetinic acid-modified curcumin-loaded cationic liposomes in vitro and in H22 tumor-bearing mice , 2018, Drug delivery.

[36]  Patrick K. Bowen,et al.  Biocompatible curcumin loaded PMMA-PEG/ZnO nanocomposite induce apoptosis and cytotoxicity in human gastric cancer cells. , 2017, Materials science & engineering. C, Materials for biological applications.

[37]  G. Ren,et al.  Curcumin Enhances the Anticancer Effect Of 5-fluorouracil against Gastric Cancer through Down-Regulation of COX-2 and NF- κB Signaling Pathways , 2017, Journal of Cancer.

[38]  Zhiwei Wang,et al.  The effects of curcumin on proliferation, apoptosis, invasion, and NEDD4 expression in pancreatic cancer , 2017, Biochemical pharmacology.

[39]  R. Rahimi,et al.  A Comprehensive Review on Pharmacotherapeutics of Three Phytochemicals, Curcumin, Quercetin, and Allicin, in the Treatment of Gastric Cancer , 2017, Journal of Gastrointestinal Cancer.

[40]  Deying Yang,et al.  Curcumin induces apoptotic cell death in human pancreatic cancer cells via the miR-340/XIAP signaling pathway. , 2017, Oncology letters.

[41]  Yanyun Li,et al.  Polydatin inhibits cell proliferation and induces apoptosis in laryngeal cancer and HeLa cells via suppression of the PDGF/AKT signaling pathway , 2017, Journal of biochemical and molecular toxicology.

[42]  A. Avan,et al.  Therapeutic Potential of Curcumin in Treatment of Pancreatic Cancer: Current Status and Future Perspectives , 2017, Journal of cellular biochemistry.

[43]  N. Jafari,et al.  Potent anti-cancer effects of less polar Curcumin analogues on gastric adenocarcinoma and esophageal squamous cell carcinoma cells , 2017, Scientific Reports.

[44]  N. Sanlier,et al.  Curcumin, an active component of turmeric (Curcuma longa), and its effects on health , 2017, Critical reviews in food science and nutrition.

[45]  Kenji Suzuki,et al.  Curcumin ameliorates liver damage and progression of NASH in NASH‐HCC mouse model possibly by modulating HMGB1‐NF‐&kgr;B translocation , 2017, International immunopharmacology.

[46]  Z. Stanić,et al.  Curcumin, a Compound from Natural Sources, a True Scientific Challenge – A Review , 2017, Plant Foods for Human Nutrition.

[47]  Jian Zhu,et al.  Celecoxib enhances anticancer effect of cisplatin and induces anoikis in osteosarcoma via PI3K/Akt pathway , 2017, Cancer Cell International.

[48]  S. Su,et al.  Advances in Synergistic Combinations of Chinese Herbal Medicine for the Treatment of Cancer , 2016, Current cancer drug targets.

[49]  Qi-wen Ben,et al.  Bulk pancreatic cancer cells can convert into cancer stem cells(CSCs) in vitro and 2 compounds can target these CSCs , 2016, Cell cycle.

[50]  J. Jia,et al.  Curcumin enhances the antitumor effect of ABT-737 via activation of the ROS-ASK1-JNK pathway in hepatocellular carcinoma cells , 2015, Molecular medicine reports.

[51]  Fei-Ting Hsu,et al.  Curcumin Sensitizes Hepatocellular Carcinoma Cells to Radiation via Suppression of Radiation-Induced NF-κB Activity , 2015, BioMed research international.

[52]  G. Leyhausen,et al.  Curcumin in Combination with Piperine Suppresses Osteoclastogenesis In Vitro. , 2015, Journal of endodontics.

[53]  R. Wu,et al.  Curcumin Suppresses MAPK Pathways to Reverse Tobacco Smoke‐induced Gastric Epithelial–Mesenchymal Transition in Mice , 2015, Phytotherapy research : PTR.

[54]  Z. Li,et al.  Paclitaxel-sensitization enhanced by curcumin involves down-regulation of nuclear factor-κB and Lin28 in Hep3B cells , 2015, Journal of receptor and signal transduction research.

[55]  Zhong-Zhen Zhao,et al.  Combinational Treatment of Curcumin and Quercetin against Gastric Cancer MGC-803 Cells in Vitro , 2015, Molecules.

[56]  C. Mathers,et al.  Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012 , 2015, International journal of cancer.

[57]  Jinshui Zhu,et al.  Curcumin suppresses lymphatic vessel density in an in vivo human gastric cancer model , 2015, Tumor Biology.

[58]  P. Yin,et al.  Ras/ERK signaling pathway is involved in curcumin-induced cell cycle arrest and apoptosis in human gastric carcinoma AGS cells , 2015, Journal of Asian natural products research.

[59]  B. Aggarwal,et al.  Curcumin Differs from Tetrahydrocurcumin for Molecular Targets, Signaling Pathways and Cellular Responses , 2014, Molecules.

[60]  Jing-Gung Chung,et al.  Suppressing the formation of lipid raft‐associated Rac1/PI3K/Akt signaling complexes by curcumin inhibits SDF‐1α‐induced invasion of human esophageal carcinoma cells , 2014, Molecular carcinogenesis.

[61]  Patrice D Cani,et al.  Curcuma longa Extract Associated with White Pepper Lessens High Fat Diet-Induced Inflammation in Subcutaneous Adipose Tissue , 2013, PloS one.

[62]  Qin Du,et al.  Synergistic anticancer effects of curcumin and resveratrol in Hepa1-6 hepatocellular carcinoma cells. , 2013, Oncology reports.

[63]  Quanyi Lu,et al.  DNMT3A mutations and clinical features in Chinese patients with acute myeloid leukemia , 2013, Cancer Cell International.

[64]  Yan Li,et al.  The association of manganese superoxide dismutase expression in Barrett's esophageal progression with MnTBAP and curcumin oil therapy. , 2012, The Journal of surgical research.

[65]  Prateek Sharma,et al.  Curcumin Induces Cell Death in Esophageal Cancer Cells through Modulating Notch Signaling , 2012, PloS one.

[66]  Shuang Huang,et al.  Curcumin improves MMC-based chemotherapy by simultaneously sensitising cancer cells to MMC and reducing MMC-associated side-effects. , 2011, European journal of cancer.

[67]  Robert C. G. Martin,et al.  Chemoprotective effects of curcumin in esophageal epithelial cells exposed to bile acids. , 2010, World journal of gastroenterology.

[68]  H. Sawada,et al.  The Biosynthetic Pathway of Curcuminoid in Turmeric (Curcuma longa) as Revealed by 13C-Labeled Precursors , 2008, Bioscience, biotechnology, and biochemistry.

[69]  C. Thomson,et al.  Nutrition and diet in the development of gastrointestinal cancer , 2003, Current oncology reports.

[70]  J. Mathers,et al.  Curcumin modifies Apc(min) apoptosis resistance and inhibits 2-amino 1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) induced tumour formation in Apc(min) mice. , 2001, Carcinogenesis.

[71]  Emily G Pendleton,et al.  Tetrahydrocurcumin, Curcumin, and 5-Fluorouracil Effects on Human Esophageal Carcinoma Cells. , 2019, Anti-cancer agents in medicinal chemistry.

[72]  Kazuhiro Yoshida,et al.  Curcumin sensitizes pancreatic cancer cells to gemcitabine by attenuating PRC2 subunit EZH2, and the lncRNA PVT1 expression , 2017, Carcinogenesis.

[73]  G. Jenkins,et al.  Curcumin abrogates bile-induced NF-κB activity and DNA damage in vitro and suppresses NF-κB activity whilst promoting apoptosis in vivo, suggesting chemopreventative potential in Barrett’s oesophagus , 2012, Clinical and Translational Oncology.